Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center

The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which ...
Mining Weekly

Global Battery Materials confirms promising economics for Kearney graphite mine restart

Vertically integrated critical minerals company Global Battery Materials has announced a positive preliminary economic ...
MUO on MSN

Windows isn't hiding your cores — that dropdown just tricks you into thinking it is

Windows was already using every core you thought you unlocked.

Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap

Detailed price information for Restart Life Sciences Corp (HEAL-CN) from The Globe and Mail including charting and trades.